Founder of ImmuneOnco Biopharmaceuticals (Shanghai) Tian Wenzhi Buys More Stock

Potential ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541) shareholders may wish to note that the Founder, Tian Wenzhi, recently bought HK$792k worth of stock, paying HK$5.28 for each share. However, it only increased shareholding by a small percentage, and it wasn’t a huge purchase by absolute value, either.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

The Last 12 Months Of Insider Transactions At ImmuneOnco Biopharmaceuticals (Shanghai)

In fact, the recent purchase by Tian Wenzhi was the biggest purchase of ImmuneOnco Biopharmaceuticals (Shanghai) shares made by an insider individual in the last twelve months, according to our records. Although we like to see insider buying, we note that this large purchase was at significantly below the recent…